The White House is betting that a new cash-pay platform—built around blockbuster GLP-1 drugs—can pressure Big Pharma and bypass the middlemen who keep U.S. pricesThe White House is betting that a new cash-pay platform—built around blockbuster GLP-1 drugs—can pressure Big Pharma and bypass the middlemen who keep U.S. prices

President Trump Launches TrumpRx, Promising Lower Drug Prices: Is It Legit?

2026/02/07 04:11
1 min read
The White House is betting that a new cash-pay platform—built around blockbuster GLP-1 drugs—can pressure Big Pharma and bypass the middlemen who keep U.S. prices high.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.